Close menu




May 25th, 2021 | 11:35 CEST

Bayer, Saturn Oil + Gas, Deutsche Lufthansa - All the ingredients for a price fireworks display!

  • Oil
Photo credits: pixabay.com

Information moves prices. Sometimes up, sometimes down, and sometimes information seems to "bounce off" - ignored or misinterpreted by market participants. It is easier said than done to correctly classify the information in relation to the long-term perspective of a company. Thus, as seen last week with Bayer and Deutsche Lufthansa, a short-term price dampener is a good opportunity to enter the market. But also, information that is complex in detail and must first be "understood", offers the chance to make a real bargain. Canadian oil and gas producer Saturn is a case in point. The Company is moving into new dimensions with an acquisition, and according to the latest analyst report, the stock has the potential to triple in value. Where will you buy?

time to read: 4 minutes | Author: Carsten Mainitz
ISIN: DE000BAY0017 , CA80412L1076 , DE0008232125

Table of contents:


    Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG
    "[...] China's dominance is one of the reasons why we are so heavily involved in the tungsten market. Here, around 85% of production is in Chinese hands. [...]" Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

    Full interview

     

    BAYER AG - 2:1

    The German life science group divides its business activities into consumer health, pharmaceuticals, and Crop Science. In the past fiscal year, Bayer generated sales of EUR 41.4 billion with around 100,000 employees. Although the pharmaceuticals business predominates in the Group, the agrochemicals activities had a negative impact on the news flow last week.

    Bayer scored a massive own goal with its 2018 acquisition of US competitor Monsanto. Its aftermath continues to this day. Monsanto's bestseller was Roundup, a weedkiller containing glyphosate that is suspected of being carcinogenic. It led to a huge wave of lawsuits. The Company was brought back down to earth last week when it felt it was on the home stretch to conclude part of the billion-euro settlement it had sought in the US legal dispute. An important judge demanded more specifics and improvements on several points. A Bayer spokesman stressed that, together with the plaintiffs' attorneys, the court's concerns would be addressed and went on to say that "we are confident that we will reach a revised settlement that is fair and reasonable. We intend to file a new motion within the next month." The renewed hang-up weighed on the share price.

    Nevertheless, the positive news outweighed the negative last week. Bayer can hope for early approval of the heart drug Verquvo in the EU. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive recommendation for the drug last Friday. The active ingredient vericiguat is used to treat certain symptomatic chronic heart failure in adults. The Company said it expects the final decision from the European Commission in the coming months. However, the drug has already been approved in the United States since January. The drug is a joint development of Bayer and the US pharmaceutical Company Merck & Co. Merck & Co. holds the marketing rights for the United States, Bayer for the rest of the world. Regulatory filings are also currently underway in other countries, including Japan and China.

    Another reason Bayer shareholders rejoice came last week from southern Germany: CureVac expects its Corona vaccine to be approved soon. Bayer had entered into an extensive collaboration with the Tübingen-based biotech start-up in January to market its COVID-19 vaccine. Plans are already underway to expand production, CureVac spokeswoman Sarah Fakih told Augsburger Allgemeine over the weekend. "We hope for approval in the second quarter," Fakih said. So - 2:1 for the team "Pharma".

    At around EUR 56, the share price is still EUR 20 away from the 2020 summer price. Given the excellent pharma prospects of the Group and the progressive workout of the glyphosate litigation in the share, it is a clear buy.

    SATURN OIL + GAS INC - Mega deal! According to analysts, the stock is a triple!

    The recently announced acquisition of the Oxbow property will catapult the emerging Canadian oil and gas producer to new heights. Saturn has entered into an agreement to purchase the Oxbow assets for approximately CAD 93 million. Oxbow's assets are located in southeastern Saskatchewan and currently produce nearly 6,700 BOE per day.

    Other important aspects are added: the Oxbow property has extensive infrastructure and facilities with direct pipeline connections to the global distribution network. These plus points strengthen the economics of the transaction. Likewise, the so-called depletion rates, i.e., the declining extraction rates or yields typical for oil production, are very low here. In addition, the new asset has an advantageous production share of gas, which is very low. Saturn will reach a production level of around 7,500 BOE per day upon completion. According to the Company, it will be possible to maintain the production level for at least 24 to 36 months after the transaction.

    The analysts at GBC have taken a closer look at the deal and point to the following key figures, which impressively underline the high profitability of the project. Already in the current fiscal year, sales are expected to jump to around CAD 146 million, enabling an EBIT margin of 53%. The Company hedges a large part of its production on the forward market. Currently, Saturn is valued at around CAD 42 million at a share price of CAD 0.18. The purchase price of the Oxbow asset is to be settled in shares and loans. Even if this means a dilution with the increase in the number of shares from the current 234 million by around 300 million shares, the "net effect" for shareholders is positive.

    The analysts of GBC formulate a price target of CAD 0.46, which you calculate based on a DCF model. If one also considers the sheer size of the land package and the replacement value, then the price target is well supported. The project covers 11,484 sq km of land. Saturn is acquiring over 1,000 producing wells, 60 major facilities, 2,500 kilometers of connected pipelines and 244 wells ready to drill. From undeveloped land to multiple well sites and pipelines, the Canadians are acquiring total assets with a replacement value of approximately CAD 1 billion!

    DEUTSCHE LUFTHANSA AG - Major shareholder sells at a considerable discount!

    No, it was neither geopolitical tensions nor the oil price that caused the share to plummet last week, but the sale of a major shareholder. A significant share placement by the Thiele family had weighed on the stock last Friday. The heirs of billionaire Heinz Hermann Thiele (owner of brake specialist Knorr-Bremse), who died in February 2021, sold 33 million share certificates at a considerable discount.

    Thiele had joined Lufthansa last year. As the Bloomberg news agency reported late Thursday evening, citing documents at its disposal, the shares were sold via the investment bank Morgan Stanley for EUR 9.80, almost 10% below the Xetra closing price! What happens to the remaining 4.5% share of the family is unclear. In addition, the market expects a new capital injection for the crane soon. Traders are waiting for the next mini-correction!


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Carsten Mainitz on June 22nd, 2022 | 13:40 CEST

    Nordex, Saturn Oil + Gas, Shell - Reality vs Idealism: Long in oil stocks!

    • Oil
    • Sustainability
    • Investments

    The idea that renewable energies will feed the world's entire energy needs is desirable but unrealistic in the short term. In the political debate in Germany, we are currently seeing how far apart the target images of "green" or "sustainable" and security of supply can be. In an exemplary manner - and this is meant with a wink - Europe's largest economy is shutting down its nuclear power plants and now suddenly realizes that its great dependence on Russia's gas supplies is creating a supply risk. Now a ramp-up of coal-fired power plants is supposed to fix it. For logical and forward-looking investors, oil stocks are worth a look.

    Read

    Commented by Armin Schulz on June 13th, 2022 | 15:45 CEST

    Alibaba, Almonty Industries, Shell - Shares with conspicuous strength in the crisis

    • Tungsten
    • Oil
    • ecommerce

    The past week was tough for many investors. First, the ECB declared on Wednesday to raise interest rates, and on Friday, it was announced that the inflation rate in the US rose to 8.6% in May. As a result of these events, the markets collapsed and a number of blue chips suffered, in some cases significantly. But even in the weak phases, some shares buck the general market trend, which is a clear sign of strength. When the market as a whole turns around, it is precisely these stocks that often benefit disproportionately. We have picked out three companies that have held up well in the falling market environment and look closely at their future prospects.

    Read

    Commented by Stefan Feulner on June 13th, 2022 | 11:56 CEST

    No bear market - Saturn Oil + Gas, BYD and Rheinmetall with new momentum

    • Oil
    • Electromobility

    Due to the great uncertainties regarding the geopolitical situation and rampant inflation concerns, the markets are correcting drastically. The broad-based US leading index, S&P 500, is at the beginning of a bear market with a loss of almost 20% since the beginning of the year. While fear and panic prevail on the global stock markets, individual stocks from various sectors are moving in the opposite direction and even posting new highs. The seeds for further growth have now been sown at a growing oil producer.

    Read